BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24390450)

  • 1. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
    BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathological findings and clinical course.
    Emerson LL; Layfield LJ; Frame R
    Histopathology; 2007 Sep; 51(3):430-2. PubMed ID: 17727493
    [No Abstract]   [Full Text] [Related]  

  • 11. Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.
    Eden BV; Debo RF; Larner JM; Kelly MD; Levine PA; Stewart FM; Cantrell RW; Constable WC
    Cancer; 1994 May; 73(10):2556-62. PubMed ID: 8174053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 20 adults esthesioneuroblastoma with combined therapy].
    Li JS; Xie FY; Peng M; Han F
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):36-9. PubMed ID: 19484986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retained role of surgery for olfactory neuroblastoma.
    Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
    Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esthesioneuroblastoma: a meta-analysis and review.
    Dulguerov P; Allal AS; Calcaterra TC
    Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality Treatment of Pediatric Esthesioneuroblastoma.
    Venkatramani R; Pan H; Furman WL; Marron JM; Haduong J; Friedrich-Medina P; Mahajan A; Bavle A; Wu H; Chintagumpala M
    Pediatr Blood Cancer; 2016 Mar; 63(3):465-70. PubMed ID: 26514449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rare tumor of the nasal cavity: esthesioneuroblastoma].
    Jouini R; Ben Brahim E; Ben Gamra O; Hriga I; Labbene N; El Khedim AK; Ben Ayed M; Chadli-Debbiche A
    Tunis Med; 2011; 89(8-9):718. PubMed ID: 21948666
    [No Abstract]   [Full Text] [Related]  

  • 19. Olfactory neuroblastoma in children: results of multimodality treatment in 2 patients.
    Küpeli S; Yalçin B; Büyükpamukçu M
    Pediatr Hematol Oncol; 2011 Feb; 28(1):56-9. PubMed ID: 21247350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
    Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.